The bottom line is, our Medicare Advantage plans rank better than ever. For 2022, we expect 89% of our Medicare Advantage and Prescription Drug Plan (MAPD) customers will be in a 4 Star rated plan or higher – up 12% in just three years.

Highlights of our 2022 Stars Ratings include:

• A 5 Star plan rating in Florida for the fourth year in a row.
• A fourth-year of 4.5 Star performance in Alabama, Tennessee, and Texas.
• A rating of 4.5 Stars in North Carolina for the second year.
• South Carolina, Arizona, and Mississippi increased to 4.5 Stars.
• Pennsylvania maintained its 4 Star ratings.
• Illinois and Georgia improved to achieve 4 Stars.
• Our North Texas PPO earned 4 Stars for the first time.

For market-specific results, please click here.

We are proud of these results and the positive impact they will have on your customers. It’s more evidence that it’s a great time to sell Cigna Medicare Advantage!